coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Eccles & Irlam PCN, Salford (LAD) · Health Inequalities Profile

    PCN U00203 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    77,884

    Registered population

    63.9% aged 18–64

    14.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    53.1%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~38,813

    Core20 residents (est.)

    Resident basis; registered basis ~42,037 · see page 3

    10,901

    Hypertension register

    +8.63% in 3 yrs · England +5.60%

    1,022

    SMI register

    27.6% of Salford (LAD)'s

    2,384

    COPD register

    Reviews +16.77% in 3 yrs

    Forecast to 2030

    12,822

    Hypertension patients, 2030

    +1,921 on today

    73.5%

    QRISK ≥20% on statins, 2030

    +2.67pp over 3 yrs

    3.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.6%
    Breast screening remains below national and local averages.

    Breast screening is 57.6% (Salford 64.9%, ICB 68.8%, England 69.9%) despite +30.1% growth over 2023 to 2024, which may reflect unverified uptake barriers.

    83.3%
    Age-five booster and second MMR doses fall short.

    Age-5 4-in-1 coverage is 83.3% (11.7 pp below the 95.0% target) and MMR drops 7.3 pp from 93.1% to 85.8% in Q1 2025/26.

    80.1%
    Strong cardiometabolic control despite slower preventive trend growth.

    Hypertension control reaches 80.1% (England 70.3%) and non-frail diabetes control 65.1% (England 57.4%), though QRISK ≥ 20% lipid growth (+4.1%) trails England (+6.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 14.1% aged 65+ sits alongside 961 care home beds

    Across 77,884 registered patients, the PCN has a younger demographic profile than England. Patients aged 65 and over form 14.1% of the list (10,974 patients), trailing Salford (14.4%), NHS Greater Manchester ICB (14.9%) and England (17.9%). Children aged 0-17 make up 22.0% (17,159 patients), above Salford (21.4%), ICB (21.8%) and England (19.6%). Census ethnicity shows Gypsy or Irish Traveller residents at 0.1% (Salford 0.1%, ICB 0.1%, England 0.1%) and Roma at 0.1% (Salford 0.2%, ICB 0.1%, England 0.2%). Registered lists represent practice counts, whereas ethnicity figures reflect resident Census estimates.

    Age profile

    0–1722.0%
    18–6463.9%
    65+14.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Salford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Salford LA)2,9802,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)90.5%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)65.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Salford LA)1,5101,0219552024/25
    Falls deaths, all ages, per 100,000 (Salford LA)15.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients form 53.1% of the list, spanning 55.6 pp between practices

    Core20 patients make up 53.1% of the registered list, above Salford (44.0%), the ICB (40.7%) and England (21.0%), though weighted practice shares (54.0%) and resident estimates (38,813) differ. Concentration spans 55.6 pp, from 24.4% at 1/monton Medical Practice to 80.1% at Salford Primary Care Together. Salford Primary Care Together also holds the largest volume with 14,944 estimated Core20 patients. Outreach and clinical capacity could focus on high-deprivation practices where the bulk of Core20 patients reside.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Salford Primary80.1% · 14,944 patients
    3/springfield66.9% · 7,648 patients
    St Andrews48.6% · 7,586 patients
    (irlam) Salford42.8% · 1,904 patients
    Mosslands Medical42.4% · 5,243 patients
    Chapel Group40.2% · 2,443 patients
    1/monton Medical24.4% · 2,269 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,022

    SMI register

    1.28% recorded prevalence

    430

    Learning disability register

    0.54% recorded prevalence

    24

    Care homes, 961 beds

    In the PCN catchment

    9.2%

    Provide unpaid care

    Salford (LAD), Census 2021

    Severe mental illness prevalence is 1.3% (1,022 patients), above Salford (1.1%), ICB (1.1%) and England (1.0%), while learning disability prevalence is 0.5% (430 patients; Salford 0.5%, ICB 0.6%, England 0.6%). The PCN catchment includes 961 care home beds. Borough rough sleeping (41 people in Salford) cannot be extrapolated to practice lists. The SMI register is above England, so physical-health checks for this group are the larger workload to protect.

    Severe mental illness: physical health checks

    SMI prevalence is 1.3% (England 1.0%). Recorded checks reached 85.3% for blood pressure (England 83.4%) and 85.1% for BMI (England 82.1%). Smoking cessation offers fell 1.2 pp over 2023 to 2025 (England +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,901

    Hypertension register

    +8.63%

    Register growth, 3 yrs

    Salford (LAD) +5.45% · England +5.60%

    +4.91pp

    BP control, under 80

    ≤140/90 · +2.58pp aged 80+

    +1,921

    More patients by 2030

    Forecast 12,822 (16.15%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.7% (10,901 patients across a registered list of 77,884), above Salford (LAD) (12.4%) but below England (15.2%) and NHS Greater Manchester Integrated Care Board (14.4%), with 3-year register growth of +8.6% (2023 to 2025; England +5.6%). Patients treated to target reached 80.1% (England 70.3%, Salford (LAD) 77.6%, ICB 71.4%). Recent blood pressure readings reached 93.8% (England 90.0%), while 3-year recording growth (+3.1% over 2023 to 2025) trails England (+3.6%). High control rates provide a solid foundation to review recall systems so recent recording gains keep pace with national trends.

    Lipids and statins

    For QRISK ≥ 20%, lipid-lowering therapy is 67.9% (England 63.6%), but 3-year growth of +4.1% (2023 to 2025) trails England (+6.2%). Statin treatment for diabetes without CVD is 77.0% (England 73.2%), trailing 3-year national growth (+1.7% vs +2.1%). Recall audits may help address trailing preventive uptake.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026174,140£1.60£1.94£1.86£278,624
    Cardiovascular (all), 2025228,660£2.42£3.15£3.33£553,357

    For lipid-regulating drugs in 2026, the PCN prescribed 174,140 items at £1.60 per item (Salford (LAD) £1.54, England £1.86, NHS Greater Manchester Integrated Care Board £1.94). The PCN spends £45,276 less than at England's unit cost across 174,140 items. Unit costs indicate expenditure rather than clinical efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +19.31%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +6.77%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.0% (Salford (LAD) 2.5%, ICB 2.3%, England 1.9%), up +9.9% over 2023 to 2025 (England +2.6%), with 82.8% reviewed (England 76.4%). Asthma prevalence is 6.9% (England 6.6%), and prescribing is 2,028 items per 1000 aged 5-19 (England 1,488). Annual asthma reviews reached 76.2% (England 65.7%), leaving an estimated scale indicator of 1,215 patients without a recorded review across the 5,116 register. Reviewing recall registers can help target unreviewed asthma patients.

    Cancer register and children's immunisation

    Cancer prevalence is 3.1% (England 3.8%). In Q1 2025/26 childhood COVER data, complete 6-in-1 coverage at 24 months reached 96.1% (target 95.0%). At age 5, MMR dose 1 is 93.1% while dose 2 is 85.8% (a 7.3 pp dose difference; 9.2 pp below the 95.0% target), and the 4-in-1 pre-school booster is 83.3% (11.7 pp below the 95.0% target). Pre-school booster drop-off indicates a need for proactive recall before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.5%

    England 91.0%

    6-in-1 complete primary course at 24 months96.1%

    England 92.2%

    MMR dose 1 at 24 months92.6%

    England 88.3%

    MMR dose 2 at age 585.8%

    England 82.8%

    4-in-1 pre-school booster at age 583.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of known-stage cancers (6,491 of 11,679) were diagnosed at stage 1 or 2 in NHS Greater Manchester ICB (England 55.3%), with known stage in 70.8% of 16,492 registrations (England 67.0%). This is 19.4 pp below the 75.0% 2028 ambition, requiring about 2,270 extra early cases annually across the ICB, despite a 3.1 pp rise since 2013. PCN breast screening is 57.6% (Salford 64.9%, England 69.9%; +30.1% over 2023 to 2024), at 47.5% at 3/springfield House Medical Practice, 50.2% at Salford Primary Care Together, and 56.0% at St Andrews Medical Centre. Screening shortfalls may delay early detection, warranting targeted practice recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% against the 85.0% 62-day cancer referral to treatment standard, trailing the target by 12.2 pp while exceeding England (71.2%) and Bolton NHS Foundation Trust (69.7%), but behind NHS Greater Manchester Integrated Care Board (75.7%) and Northern Care Alliance NHS Foundation Trust (78.6%). On the 28-day faster diagnosis standard, Manchester University NHS Foundation Trust reached 80.1%, surpassing the 75.0% standard by 5.1 pp, above England (79.3%) and the ICB (79.5%). Treatment pathway delays beyond diagnosis highlight the need for close primary-secondary care tracking.

    Pathways within standard (%)ManchesterNorthern Care AllianceBoltonGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2080.4879.5379.32
    31-day treatment (96%)92.5494.5496.5096.4992.50
    62-day referral to treatment (85%)72.8578.6569.6675.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceBoltonEngland
    MRI11.685.092.0521.40
    CT14.664.1019.409.92
    Echocardiography4.9131.483.4828.48
    Colonoscopy4.5140.041.3330.83
    Gastroscopy29.3536.482.0629.02
    All 15 DM01 tests8.9815.7115.7823.14
    Community services activitySalford residentsGreater Manchester ICB
    Care contacts37,955573,310
    Referrals3,34094,470
    Patients with a contact15,440183,535

    Community services (residents of Salford), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 53.9% of all community service contacts among Salford residents (20,470 of 37,955 contacts). High older-adult contact volume across community pathways underscores the importance of coordinating community services with primary care cancer monitoring.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    St Andrews10848.682.6%83.3%92.2%
    Chapel Group9140.288.0%71.1%89.5%
    (irlam) Salford10842.893.2%76.2%88.5%
    3/springfield11966.966.4%76.9%83.7%
    Mosslands Medical10542.451.2%57.0%75.6%
    Salford Primary12680.157.8%81.9%73.6%
    1/monton Medical9624.449.5%71.2%71.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSalford (LAD)AssetPCNSalford (LAD)
    Care homes (catchment)24 (961 beds)n/aSchools (catchment)114n/a
    Children's centres616Places of worship55118
    Libraries816Primary schools (LA maintained)2652
    Primary academies1221

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Annual asthma reviews reached 76.2% (England 65.7%) across the 5,116 register, leaving a scale indicator of 1,215 unreviewed patients. For discussion: the PCN could run structured recall using a single review template and flexible after-school or holiday slots in high-Core20 practices. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 233), age-5 4-in-1 coverage is 83.3% (11.7 pp below 95.0%) and MMR2 is 85.8% (9.2 pp below 95.0%; 7.3 pp below MMR1 at 93.1%). For discussion: practices could audit age-5 registration lists for unrecorded second MMR and 4-in-1 booster doses and offer flexible catch-up clinic times. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Preventive CVD and smoking recall

    Over 2023 to 2025, 4 measures trail England: QRISK >= 20% lipid therapy (+4.1% vs +6.2%), smoking cessation offers (-1.2 pp vs +0.1 pp), diabetes statins (+1.7% vs +2.1%), and recent BP recording (+3.1% vs +3.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult case finding review (p2)Registered population · Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 proactive outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation prompt audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Practice phone access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% target · Core20PLUS5 · 10YHP equity testPCN
    Option 3 · Preventive CVD and smoking recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15